Drugs in clinical trial

From DrugPedia: A Wikipedia for Drug discovery

(Difference between revisions)
Jump to: navigation, search
(New page: A table showing drug in clinical trial for alzheimer's diasease {| |Name |OTHER NAMES FDA PHASE NAME: AAB-001 OTHER NAMES: Bapineuzumab, Humanized monoclonal anti-Aβ antibody FDA PHAS...)
Line 1: Line 1:
-
A table showing drug in clinical trial for alzheimer's diasease
+
A table showing drug in clinical trial for Alzheimer's disease
-
{|
+
{| border="1;width:100%; height:200px;style=text-align:center"
-
|Name
+
|+'''Table I:'''
-
|OTHER NAMES
+
|-
-
FDA PHASE
+
! style="background:brown; color:white" |Name
-
NAME: [[AAB-001]]
+
! style="background:brown; color:white" |OTHER NAMES
-
OTHER NAMES: Bapineuzumab, Humanized monoclonal anti-Aβ antibody
+
! style="background:brown; color:white" |FDA PHASE
-
FDA PHASE: Phase III
+
|-
-
 
+
|AAB-001
-
NAME: ACC-001
+
|Bapineuzumab, Humanized monoclonal anti-Aβ antibody
-
FDA PHASE: Phase I
+
|Phase III
-
 
+
|-
-
NAME: Acetyl-l-carnitine HCI
+
|ACC-001
-
OTHER NAMES: ALCAR
+
|
-
FDA PHASE: Discontinued
+
|Phase I
-
 
+
|-
-
NAME: AF 102B
+
|Acetyl-l-carnitine HCI
-
OTHER NAMES: cevimeline HCL, Evoxac™
+
|ALCAR
-
FDA PHASE: Discontinued
+
|Discontinued
-
 
+
|-
-
NAME: Alpha-tocopherol
+
|AF 102B
-
OTHER NAMES: Vitamin E
+
|cevimeline HCL, Evoxac™
-
 
+
|Discontinued
-
NAME: Alzhemed™
+
|-
-
OTHER NAMES:  3-amino-1-propanesulfonic acid, 3-aminopropylsulfonic acid, 3-APS, homotaurine, NC-531, Tramiprosate
+
|Alpha-tocopherol
-
FDA PHASE: Phase III
+
|Vitamin E
-
 
+
|Discontinued
-
NAME: AN 1792
+
|-
-
OTHER NAMES: AIP 001
+
|Alzhemed™
-
FDA PHASE: Discontinued
+
|3-amino-1-propanesulfonic acid, 3-aminopropylsulfonic acid, 3-APS, homotaurine, NC-531, Tramiprosate
-
 
+
|Phase III
-
NAME: Atorvastatin
+
|-
-
OTHER NAMES: Lipitor™
+
|AN 1792
-
FDA PHASE: Phase II/IIa/IIb
+
|AIP 001
-
 
+
|Discontinued
-
NAME: AZD3480
+
|-
-
OTHER NAMES: ispronicline, TC-1734
+
|Atorvastatin
-
FDA PHASE: Phase II/IIa/IIb
+
|Lipitor™
-
 
+
|Phase II/IIa/IIb
-
NAME: Besipirdine HCl
+
|-
-
OTHER NAMES: HP 749
+
|AZD3480
-
FDA PHASE: Discontinued
+
|ispronicline, TC-1734
-
 
+
|Phase II/IIa/IIb
-
NAME: Beta- & Gamma-Secretase Inhibitors
+
|-
-
FDA PHASE: Preclinical
+
|Besipirdine HCl
-
 
+
|HP 749
-
NAME: Cerebrolysin
+
|Discontinued
-
FDA PHASE: Approved outside U.S.
+
|-
-
 
+
|Beta- & Gamma-Secretase Inhibitors
-
NAME: Clioquinol
+
|
-
OTHER NAMES: iodochlorhydroxyquin, PBT-1
+
|Preclinical
-
FDA PHASE: Discontinued
+
|-
-
 
+
|Cerebrolysin
-
NAME: COGNIShunt™
+
|
-
FDA PHASE: Phase II/IIa/IIb
+
|Approved outside U.S.
-
 
+
|-
-
NAME: CX516
+
|Clioquinol
-
OTHER NAMES: Ampalex
+
|iodochlorhydroxyquin, PBT-1
-
FDA PHASE: Phase II/IIa/IIb
+
|Discontinued
-
 
+
|-
-
NAME: Dapsone
+
|COGNIShunt™
-
OTHER NAMES: Avlosulfon
+
|
-
FDA PHASE: Phase II/IIa/IIb
+
|Phase II/IIa/IIb
-
 
+
|-
-
NAME: Dimebon
+
|CX516
-
OTHER NAMES: 3,6-dimethyl-9-(2-methyl-pyridyl-5)-ethyl-1,2,3,4-tetrahydro-γ-carboline dihydrochloride
+
|Ampalex
-
FDA PHASE: Phase II/IIa/IIb
+
|Phase II/IIa/IIb
-
 
+
|-
-
 
+
|Dapsone
-
NAME: Docosahexanoic acid (DHA)
+
|Avlosulfon
-
OTHER NAMES: Omega 3 fatty acids
+
|Phase II/IIa/IIb
-
FDA PHASE: Phase III
+
|-
-
 
+
|Dimebon
-
NAME: Donepezil
+
|3,6-dimethyl-9-(2-methyl-pyridyl-5)-ethyl-1,2,3,4-tetrahydro-γ-carboline dihydrochloride
-
OTHER NAMES: Aricepts™
+
|Phase II/IIa/IIb
-
FDA PHASE: FDA approved
+
|-
-
MECHANISMS: cholinesterase inhibitors
+
|Docosahexanoic acid (DHA)
-
ROLE IN ALZHEIMER'S DISEASE: Improves cognition, global function, and activities of daily living.
+
|Omega 3 fatty acids
 +
|Phase III
 +
|-
 +
|Donepezil
 +
|Aricepts™
 +
|FDA approved
 +
|-
 +
|Eptastigmine
 +
|MF 201
 +
|Discontinued
 +
|-
 +
|Estrogen
 +
|Premarin™
 +
|Phase III
 +
|-
 +
|Exelon™
 +
|Rivastigmine tartrate
 +
|FDA approved
 +
|-
 +
|Flurizan™
 +
|MPC-7869, r-flurbiprofen, tarenflurbil
 +
|Discontinued
 +
|-
 +
|Galantamine
 +
|Reminyl™
 +
|FDA approved
 +
|-
 +
|Huperzine A
 +
|Cerebra capsule, Pharmassure Memorall capsule
 +
|Phase II/IIa/IIb
 +
|-
 +
|Ibuprofen
 +
|Advil™, Motrin™, Nuprin™
 +
|Phase III
 +
|-
 +
|Idebenone
 +
|
 +
|Discontinued
 +
|-
 +
|Intravenous Immunoglobulin
 +
|IVIg
 +
|Phase II/IIa/IIb
 +
|-
 +
|Leuprolide
 +
|Leuprolide acetate
 +
|Phase III
 +
|-
 +
|Linopirdine
 +
|DuP996
 +
|Discontinued
 +
|-
 +
|LU25-109
 +
|
 +
|Discontinued
 +
|-
 +
|LY450139 Dihydrate
 +
|hydroxylvaleryl monobenzocaprolactam
 +
|Phase III
 +
|-
 +
|Melatonin
 +
|
 +
|Not FDA regulated
 +
|-
 +
|MEM 1003
 +
|
 +
|Phase II/IIa/IIb
 +
|-
 +
|Memantine
 +
|Ebixa™, Namenda™
 +
|FDA approved
 +
|-
 +
|Metrifonate
 +
|
 +
|Discontinued
 +
|-
 +
|Milameline
 +
|CI 979
 +
|
 +
|-
 +
|MKC-231
 +
|
 +
|Phase II/IIa/IIb
 +
|-
 +
|NAME: Naproxen
 +
|Aleve™, Anaprox™, Naprosyn™
 +
|Phase III
 +
|-
 +
|Nefiracetam
 +
|
 +
|Phase II/IIa/IIb
 +
|-
 +
|NeoTrofin
 +
|AIT-082
 +
|Phase II/III
 +
|-
 +
|Neramexane
 +
|1-amino-1,3,3,5,5-pentamethyl-cyclohexane hydrochloride, MRZ 2/579
 +
|Phase III
 +
|-
 +
|Nerve Growth Factor Gene Therapy
 +
|Nerve Growth Factor
 +
|Phase II/IIa/IIb
 +
|-
 +
|NGX267
 +
|AF267B
 +
|Phase I
 +
|-
 +
|NS2330
 +
|
 +
|Phase II/IIa/IIb
 +
|-
 +
|PBT2
 +
|
 +
|Phase II/IIa/IIb
 +
|-
 +
|Phenserine
 +
|
 +
|Inactive
 +
|-
 +
|Physostigmine Salicylate
 +
|Synapton
 +
|Discontinued
 +
|-
 +
|Propentofylline
 +
|
 +
|HWA 285
 +
|-
 +
|PRX-0314
 +
|7-isopropyl-6-oxo-5(3-piperidin-1-yl-propylcarbamoyl)-6,7-dihydro-thieno[2,3-b]pyridine-4-olate, potassium salt
 +
|Phase I
 +
|-
 +
|Rofecoxib
 +
|Vioxx™
 +
|Phase III
 +
|-
 +
|Rosiglitazone
 +
|5-[[4-[2-(methyl-pyridin-2-yl-amino)ethoxy]phenyl]methyl]thiazolidine-2,4-dione, AVANDIA®, Rosiglitazone maleate
 +
|Phase III
 +
|-
 +
|Sabeluzole
 +
|R58735
 +
|Discontinued
 +
|-
 +
|SB 202026
 +
|Memric, Sabcomeline
 +
|Discontinued
 +
|-
 +
|SGS-742
 +
|CGP-36742, DVD-742
 +
|Phase II/IIa/IIb
 +
|-
 +
|Simvastatin
 +
|Zocor®
 +
|Phase III
 +
|-
 +
|Statins
 +
|
 +
|Phase II/IIa/IIb
 +
|-
 +
|Suritozole
 +
|MD 26,479
 +
|Discontinued
 +
|-
 +
|Tacrine
 +
|Cognex™
 +
|FDA approved
 +
|-
 +
|Valproate
 +
|Depakene (valproic acid or sodium valproate), Depakote (divalproex sodium)
 +
|Phase III
 +
|-

Revision as of 11:19, 18 August 2008

A table showing drug in clinical trial for Alzheimer's disease

Table I:
Name OTHER NAMES FDA PHASE
AAB-001 Bapineuzumab, Humanized monoclonal anti-Aβ antibody Phase III
ACC-001 Phase I
Acetyl-l-carnitine HCI ALCAR Discontinued
AF 102B cevimeline HCL, Evoxac™ Discontinued
Alpha-tocopherol Vitamin E Discontinued
Alzhemed™ 3-amino-1-propanesulfonic acid, 3-aminopropylsulfonic acid, 3-APS, homotaurine, NC-531, Tramiprosate Phase III
AN 1792 AIP 001 Discontinued
Atorvastatin Lipitor™ Phase II/IIa/IIb
AZD3480 ispronicline, TC-1734 Phase II/IIa/IIb
Besipirdine HCl HP 749 Discontinued
Beta- & Gamma-Secretase Inhibitors Preclinical
Cerebrolysin Approved outside U.S.
Clioquinol iodochlorhydroxyquin, PBT-1 Discontinued
COGNIShunt™ Phase II/IIa/IIb
CX516 Ampalex Phase II/IIa/IIb
Dapsone Avlosulfon Phase II/IIa/IIb
Dimebon 3,6-dimethyl-9-(2-methyl-pyridyl-5)-ethyl-1,2,3,4-tetrahydro-γ-carboline dihydrochloride Phase II/IIa/IIb
Docosahexanoic acid (DHA) Omega 3 fatty acids Phase III
Donepezil Aricepts™ FDA approved
Eptastigmine MF 201 Discontinued
Estrogen Premarin™ Phase III
Exelon™ Rivastigmine tartrate FDA approved
Flurizan™ MPC-7869, r-flurbiprofen, tarenflurbil Discontinued
Galantamine Reminyl™ FDA approved
Huperzine A Cerebra capsule, Pharmassure Memorall capsule Phase II/IIa/IIb
Ibuprofen Advil™, Motrin™, Nuprin™ Phase III
Idebenone Discontinued
Intravenous Immunoglobulin IVIg Phase II/IIa/IIb
Leuprolide Leuprolide acetate Phase III
Linopirdine DuP996 Discontinued
LU25-109 Discontinued
LY450139 Dihydrate hydroxylvaleryl monobenzocaprolactam Phase III
Melatonin Not FDA regulated
MEM 1003 Phase II/IIa/IIb
Memantine Ebixa™, Namenda™ FDA approved
Metrifonate Discontinued
Milameline CI 979
MKC-231 Phase II/IIa/IIb
NAME: Naproxen Aleve™, Anaprox™, Naprosyn™ Phase III
Nefiracetam Phase II/IIa/IIb
NeoTrofin AIT-082 Phase II/III
Neramexane 1-amino-1,3,3,5,5-pentamethyl-cyclohexane hydrochloride, MRZ 2/579 Phase III
Nerve Growth Factor Gene Therapy Nerve Growth Factor Phase II/IIa/IIb
NGX267 AF267B Phase I
NS2330 Phase II/IIa/IIb
PBT2 Phase II/IIa/IIb
Phenserine Inactive
Physostigmine Salicylate Synapton Discontinued
Propentofylline HWA 285
PRX-0314 7-isopropyl-6-oxo-5(3-piperidin-1-yl-propylcarbamoyl)-6,7-dihydro-thieno[2,3-b]pyridine-4-olate, potassium salt Phase I
Rofecoxib Vioxx™ Phase III
Rosiglitazone 5-[[4-[2-(methyl-pyridin-2-yl-amino)ethoxy]phenyl]methyl]thiazolidine-2,4-dione, AVANDIA®, Rosiglitazone maleate Phase III
Sabeluzole R58735 Discontinued
SB 202026 Memric, Sabcomeline Discontinued
SGS-742 CGP-36742, DVD-742 Phase II/IIa/IIb
Simvastatin Zocor® Phase III
Statins Phase II/IIa/IIb
Suritozole MD 26,479 Discontinued
Tacrine Cognex™ FDA approved
Valproate Depakene (valproic acid or sodium valproate), Depakote (divalproex sodium) Phase III
Retrieved from "http://277988.efsst.group/drugpedia/index.php/Drugs_in_clinical_trial"